10 research outputs found
Two distinct pathways for the invasion of Streptococcus pyogenes in non-phagocytic cells
Repression of virulence genes by phosphorylation-dependent oligomerization ofCsrR at target promoters in S. pyogenes
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/74006/1/j.1365-2958.2001.02441.x.pd
Repression of virulence genes by phosphorylation-dependent oligomerization ofCsrR at target promoters in S. pyogenes
Cysteine proteinase SpeB from Streptococcus pyogenes – a potent modifier of immunologically important host and bacterial proteins
The identification of rofA, a positive-acting regulatory component of prtF expression: use of an m??-based shuttle mutagenesis strategy in Streptococcus pyogenes
Molecular models accounting for the gene conversion reactions mediating gonococcal pilin antigenic variation
A New Parabolized Navier-Stokes Algorithm and its Applications in Some Hypersonic Propulsion Aerodynamic Problems
Molecular analysis of the role of streptococcal pyrogenic exotoxin A (SPEA) in invasive soft-tissue infection resulting from Streptococcus pyogenes
Epidemiological studies strongly implicate the bacterial superantigen, streptococcal pyrogenic exotoxin A (SPEA), in the pathogenesis of necrotizing soft-tissue infection and toxic shock syndrome resulting from Streptococcus pyogenes. SPEA can act as a superantigen and cellular toxin ex vivo, but its role during invasive streptococcal infection is unclear. We have disrupted the wild-type spea gene in an M1 streptococcal isolate. Supernatants from toxin-negative mutant bacteria demonstrated a 50% reduction in pro-mitogenic activity in HLA DQ-positive murine splenocyte culture, and up to 20% reduction in activity in human PBMC culture. Mutant and wild-type bacteria were then compared in mouse models of bacteraemia and streptococcal muscle infection. Disruption of spea was not associated with attenuation of virulence in either model. Indeed, a paradoxical increase in mutant strain-induced mortality was seen after intravenous infection. Intramuscular infection with the SPEA-negative mutant led to increased bacteraemia at 24 h and a reduction in neutrophils at the site of primary muscle infection. Purified SPEA led to a dose-dependent increase in peritoneal neutrophils 6 h after administration. SPEA is not a critical virulence factor in invasive soft-tissue infection or bacteraemia caused by S. pyogenes, and it could have a protective role in murine immunity to pyogenic infection. The role of this toxin may be different in hosts with augmented superantigen responsiveness